Format

Send to

Choose Destination
See comment in PubMed Commons below
Surgeon. 2009 Aug;7(4):232-7.

Squamous cell carcinoma of the anal canal.

Author information

  • 1Department of Colorectal Surgery, Mayo General Hospital, Castlebar, Co. Mayo, Ireland. fiachra1978@yahoo.com

Abstract

Squamous cell carcinoma ofthe anal canal represents 1.5% of all malignancies affectingthe gastrointestinal tract. Over the past 20 years dramatic changes have been seen in both the epidemiological distribution of the disease and in the therapeutic modalities utilised to manage it.

CLINICAL MANAGEMENT:

Historically abdominoperineal resection had been the treatment of choice with local resection reserved for early stage disease. Work by Nigro et al. has revolutionised how we currently manage carcinoma of the anal canal, demonstrating combined modality chemoradiotherapy as an appropriate alternative to surgical resection with the benefit of preserving sphincter function. Surgery is then reserved for recurrent disease with salvage abdominoperineal resection. This article reviews current literature and highlights the changing therapeutic modalities with selected clinical cases

PMID:
19736891
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center